Status:
COMPLETED
Ultrasound vs. Surgical ESP Block With Bupivacaine-Dexmedetomidine in Lumbar Fusion Surgery
Lead Sponsor:
Fayoum University Hospital
Conditions:
Post Operative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Lumbar spine surgery causes intense post-op pain, peaking within 12 hours and improving by day three. Traditional spinal procedures involve extensive tissue dissection, leading to severe pain and pote...
Detailed Description
After approval of the local institutional ethics committee and local institutional review board. Patients scheduled for elective lumbar spinal Fusion surgeries and fulfilling the inclusion criteria in...
Eligibility Criteria
Inclusion
- \- American Society of Anesthesiologists (ASA) I-Ⅲ patients scheduled for elective two or three levels of lumbar spinal fusion surgeries by the same surgical team.
Exclusion
- Patient refusal.
- Body mass index \> 30 kg/m2
- Significant renal, hepatic, or cardiovascular diseases.
- History of allergy to one of the study drugs (local anesthetics, opioids, or dexmedetomidine).
- Any contraindications to regional anesthesia like local infection or abnormal coagulation function.
- Pregnant or breastfeeding women.
- Chronic opioid use, history of chronic pain, or cognitive disorders.
- Emergent surgeries.
Key Trial Info
Start Date :
May 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06958718
Start Date
May 6 2025
End Date
August 31 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fayoum University hospital
Al Fayyum, Fayoum Governorate, Egypt, 63514